Selected research
Industry Research
Darbepoetin Alpha Injection Industry Research Report 2026
Market perspective
The global Darbepoetin Alpha Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Darbepoetin Alpha Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Darbepoetin Alpha Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Darbepoetin Alpha Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Darbepoetin Alpha Injection include Kyowa Kirin, Jiangsu Hengrui Medicine, Amgen, Torii Pharmaceutical, Qilu Pharmaceutical, Chugai Pharmaceutical and China Resources Double-Crane Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Darbepoetin Alpha Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Darbepoetin Alpha Injection Market by Company
Kyowa Kirin
Jiangsu Hengrui Medicine
Amgen
Torii Pharmaceutical
Qilu Pharmaceutical
Chugai Pharmaceutical
China Resources Double-Crane Pharmaceutical
Darbepoetin Alpha Injection Segment by Type
10ug/0.5mL
20ug/0.5mL
30ug/0.5mL
40ug/0.5mL
60ug/0.5mL
Darbepoetin Alpha Injection Segment by Application
Hospital
Clinic
Others
Darbepoetin Alpha Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Darbepoetin Alpha Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Darbepoetin Alpha Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Darbepoetin Alpha Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Darbepoetin Alpha Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Darbepoetin Alpha Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Darbepoetin Alpha Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10ug/0.5mL
- 20ug/0.5mL
- 30ug/0.5mL
- 40ug/0.5mL
- 60ug/0.5mL
Applications
- Hospital
- Clinic
- Others
Companies covered
- Kyowa Kirin
- Jiangsu Hengrui Medicine
- Amgen
- Torii Pharmaceutical
- Qilu Pharmaceutical
- Chugai Pharmaceutical
- China Resources Double-Crane Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Darbepoetin Alpha Injection Market Size (2021-2032)
- 2.2.2 Global Darbepoetin Alpha Injection Sales (2021-2032)
- 2.2.3 Global Darbepoetin Alpha Injection Market Average Price (2021-2032)
- 2.3 Darbepoetin Alpha Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 10ug/0.5mL
- 2.3.3 20ug/0.5mL
- 2.3.4 30ug/0.5mL
- 2.3.5 40ug/0.5mL
- 2.3.6 60ug/0.5mL
- 2.4 Darbepoetin Alpha Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Darbepoetin Alpha Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Darbepoetin Alpha Injection Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Darbepoetin Alpha Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Darbepoetin Alpha Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Darbepoetin Alpha Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Darbepoetin Alpha Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Darbepoetin Alpha Injection, Product Type & Application
- 3.8 Global Manufacturers of Darbepoetin Alpha Injection, Established Date
- 3.9 Global Darbepoetin Alpha Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Kyowa Kirin
- 4.1.1 Kyowa Kirin Company Information
- 4.1.2 Kyowa Kirin Business Overview
- 4.1.3 Kyowa Kirin Darbepoetin Alpha Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Kyowa Kirin Darbepoetin Alpha Injection Product Portfolio
- 4.1.5 Kyowa Kirin Recent Developments
- 4.2 Jiangsu Hengrui Medicine
- 4.2.1 Jiangsu Hengrui Medicine Company Information
- 4.2.2 Jiangsu Hengrui Medicine Business Overview
- 4.2.3 Jiangsu Hengrui Medicine Darbepoetin Alpha Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Jiangsu Hengrui Medicine Darbepoetin Alpha Injection Product Portfolio
- 4.2.5 Jiangsu Hengrui Medicine Recent Developments
- 4.3 Amgen
- 4.3.1 Amgen Company Information
- 4.3.2 Amgen Business Overview
- 4.3.3 Amgen Darbepoetin Alpha Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Amgen Darbepoetin Alpha Injection Product Portfolio
- 4.3.5 Amgen Recent Developments
- 4.4 Torii Pharmaceutical
- 4.4.1 Torii Pharmaceutical Company Information
- 4.4.2 Torii Pharmaceutical Business Overview
- 4.4.3 Torii Pharmaceutical Darbepoetin Alpha Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Torii Pharmaceutical Darbepoetin Alpha Injection Product Portfolio
- 4.4.5 Torii Pharmaceutical Recent Developments
- 4.5 Qilu Pharmaceutical
- 4.5.1 Qilu Pharmaceutical Company Information
- 4.5.2 Qilu Pharmaceutical Business Overview
- 4.5.3 Qilu Pharmaceutical Darbepoetin Alpha Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Qilu Pharmaceutical Darbepoetin Alpha Injection Product Portfolio
- 4.5.5 Qilu Pharmaceutical Recent Developments
- 4.6 Chugai Pharmaceutical
- 4.6.1 Chugai Pharmaceutical Company Information
- 4.6.2 Chugai Pharmaceutical Business Overview
- 4.6.3 Chugai Pharmaceutical Darbepoetin Alpha Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Chugai Pharmaceutical Darbepoetin Alpha Injection Product Portfolio
- 4.6.5 Chugai Pharmaceutical Recent Developments
- 4.7 China Resources Double-Crane Pharmaceutical
- 4.7.1 China Resources Double-Crane Pharmaceutical Company Information
- 4.7.2 China Resources Double-Crane Pharmaceutical Business Overview
- 4.7.3 China Resources Double-Crane Pharmaceutical Darbepoetin Alpha Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 China Resources Double-Crane Pharmaceutical Darbepoetin Alpha Injection Product Portfolio
- 4.7.5 China Resources Double-Crane Pharmaceutical Recent Developments
5 Global Darbepoetin Alpha Injection Market Scenario by Region
- 5.1 Global Darbepoetin Alpha Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Darbepoetin Alpha Injection Sales by Region: 2021-2032
- 5.2.1 Global Darbepoetin Alpha Injection Sales by Region: 2021-2026
- 5.2.2 Global Darbepoetin Alpha Injection Sales by Region: 2027-2032
- 5.3 Global Darbepoetin Alpha Injection Revenue by Region: 2021-2032
- 5.3.1 Global Darbepoetin Alpha Injection Revenue by Region: 2021-2026
- 5.3.2 Global Darbepoetin Alpha Injection Revenue by Region: 2027-2032
- 5.4 North America Darbepoetin Alpha Injection Market Facts & Figures by Country
- 5.4.1 North America Darbepoetin Alpha Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Darbepoetin Alpha Injection Sales by Country (2021-2032)
- 5.4.3 North America Darbepoetin Alpha Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Darbepoetin Alpha Injection Market Facts & Figures by Country
- 5.5.1 Europe Darbepoetin Alpha Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Darbepoetin Alpha Injection Sales by Country (2021-2032)
- 5.5.3 Europe Darbepoetin Alpha Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Darbepoetin Alpha Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Darbepoetin Alpha Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Darbepoetin Alpha Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Darbepoetin Alpha Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Darbepoetin Alpha Injection Market Facts & Figures by Country
- 5.7.1 South America Darbepoetin Alpha Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Darbepoetin Alpha Injection Sales by Country (2021-2032)
- 5.7.3 South America Darbepoetin Alpha Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Darbepoetin Alpha Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Darbepoetin Alpha Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Darbepoetin Alpha Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Darbepoetin Alpha Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Darbepoetin Alpha Injection Sales by Type (2021-2032)
- 6.1.1 Global Darbepoetin Alpha Injection Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Darbepoetin Alpha Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Darbepoetin Alpha Injection Revenue by Type (2021-2032)
- 6.2.1 Global Darbepoetin Alpha Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Darbepoetin Alpha Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Darbepoetin Alpha Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Darbepoetin Alpha Injection Sales by Application (2021-2032)
- 7.1.1 Global Darbepoetin Alpha Injection Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Darbepoetin Alpha Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Darbepoetin Alpha Injection Revenue by Application (2021-2032)
- 7.2.1 Global Darbepoetin Alpha Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Darbepoetin Alpha Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Darbepoetin Alpha Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Darbepoetin Alpha Injection Value Chain Analysis
- 8.1.1 Darbepoetin Alpha Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Darbepoetin Alpha Injection Production Mode & Process
- 8.2 Darbepoetin Alpha Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Darbepoetin Alpha Injection Distributors
- 8.2.3 Darbepoetin Alpha Injection Customers
9 Global Darbepoetin Alpha Injection Analyzing Market Dynamics
- 9.1 Darbepoetin Alpha Injection Industry Trends
- 9.2 Darbepoetin Alpha Injection Industry Drivers
- 9.3 Darbepoetin Alpha Injection Industry Opportunities and Challenges
- 9.4 Darbepoetin Alpha Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst